Bioactive IGF-1 release from collagen–GAG scaffold to enhance cartilage repair in vitro
Open Access
- 11 January 2015
- journal article
- biocompatibility studies
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 26 (1) , 1-8
Abstract
Tissue engineering is a promising technique for cartilage repair. Toward this goal, a porous collagen–glycosaminoglycan (CG) scaffold was loaded with different concentrations of insulin-like growth factor-1 (IGF-1) and evaluated as a growth factor delivery device. The biological response was assessed by monitoring the amount of type II collagen and proteoglycan synthesised by the chondrocytes seeded within the scaffolds. IGF-1 release was dependent on the IGF-1 loading concentration used to adsorb IGF-1 onto the CG scaffolds and the amount of IGF-1 released into the media was highest at day 4. This initial IGF-1 release could be modelled using linear regression analysis. Osteoarthritic (OA) chondrocytes seeded within scaffolds containing adsorbed IGF-1 deposited decorin and type II collagen in a dose dependent manner and the highest type II collagen deposition was achieved via loading the scaffold with 50 μg/ml IGF-1. Cells seeded within the IGF-1 loaded scaffolds also deposited more extracellular matrix than the no growth factor control group thus the IGF-1 released from the scaffold remained bioactive and exerted an anabolic effect on OA chondrocytes. The effectiveness of adsorbing IGF-1 onto the scaffold may be due to protection of the molecule from proteolytic digestion allowing a more sustained release of IGF-1 over time compared to adding multiple doses of exogenous growth factor. Incorporating IGF-1 into the CG scaffold provided an initial therapeutic burst release of IGF-1 which is beneficial in initiating ECM deposition and repair in this in vitro model and shows potential for developing this delivery device in vivo.Keywords
This publication has 57 references indexed in Scilit:
- Binding and Release Characteristics of Insulin-Like Growth Factor-1 from a Collagen–Glycosaminoglycan ScaffoldTissue Engineering Part C: Methods, 2010
- Biologically active collagen-based scaffolds: advances in processing and characterizationPhilosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2010
- Challenges in tissue engineeringJournal of The Royal Society Interface, 2006
- Aging bone and cartilage: cross-cutting issuesBiochemical and Biophysical Research Communications, 2004
- Chondrocyte apoptosis induced by hydrogen peroxide requires caspase activation but not mitochondrial pore transitionJournal of Orthopaedic Research, 2004
- Synthesis of insulin‐like growth factor binding protein 3 in vitro in human articular cartilage culturesArthritis & Rheumatism, 2003
- Articular cartilage repair: basic science and clinical progress. A review of the current status and prospectsOsteoarthritis and Cartilage, 2002
- Phenotypic expression of equine articular chondrocytes grown in three-dimensional cultures supplemented with supraphysiologic concentrations of insulin-like growth factor-IAmerican Journal of Veterinary Research, 2002
- Responsiveness of bovine chondrocytes to growth factors in medium with different serum concentrationsJournal of Orthopaedic Research, 2000
- Coordinate upregulation of cartilage matrix synthesis in fibrin cultures supplemented with exogenous insulin‐like growth factor‐IJournal of Orthopaedic Research, 1999